Physician profile
Jay Nitin Patel
NPI 1033479100
$1,544.60
in general payments reported to CMS, 2019-2025
12 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2021: $48.92 · 2023: $971 · 2024: $68.90 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795 · Travel and Lodging: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.35 |
| Travel and Lodging | $478.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $494.69 | 2023-2024 | Cardiomems, Xience Skypoint |
| Telix Pharmaceuticals | $256.77 | 2023 | Illuccix |
| Stryker Corporation | $234.55 | 2025 | Artix Mt |
| Janssen Pharmaceuticals, INC | $113.81 | 2019 | |
| Medtronic, INC. | $112.51 | 2023 | Corevalve Evolut R, Onyx Frontier |
| Abbvie INC. | $107.57 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.19 | 2023 | Lifevest |
| Cvrx, INC. | $54.62 | 2023 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $48.92 | 2021 | |
| Atricure, INC. | $33.89 | 2024 | |
| Tactile Systems Technology INC | $32.08 | 2023-2024 | Flexitouch Plus, Entre Plus |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.